Rocket Pharmaceuticals, Inc. (FRA:9IP1)
Germany · Delayed Price · Currency is EUR 2.754
+0.256 (10.25%)
At close: Nov 28, 2025
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of €294.17 million as of December 1, 2025. Its market cap has decreased by -78.64% in one year.
Market Cap
294.17M
Enterprise Value
124.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.75
Market Cap Chart
Since January 5, 2018, Rocket Pharmaceuticals's market cap has decreased from 343.87M to 294.17M, a decrease of -14.45%. That is a compound annual growth rate of -1.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 319.19M | -74.81% |
| Dec 31, 2024 | 1.27B | -48.17% |
| Dec 29, 2023 | 2.44B | 76.39% |
| Dec 30, 2022 | 1.39B | 12.04% |
| Dec 31, 2021 | 1.24B | -54.45% |
| Dec 31, 2020 | 2.72B | 147.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |